Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

102 results about "Streptococcal disease" patented technology

Streptococcus is a common bacterium in and on our bodies. Most types of streptococcus are harmless, but some are responsible for diseases such as pneumonia, tooth decay, strep throat, scarlet fever, rheumatic fever, impetigo, and necrotizing fasciitis (flesh-eating disease). At least one type is beneficial, however.

Feed for improving streptococcal disease resistance of tilapia and feeding method thereof

The invention discloses a feed for improving streptococcal disease resistance of tilapia, and the feed is characterized in that: the feed is tilapia base daily ration particles containing 1% and 2% (by weight) of a compound Chinese herbal medicine water extraction solution; the compound Chinese herbal medicine water extraction solution comprises: by weight, 15% of licorice, 5% of perilla leaf, 20% of cordate houttuynia, 10% of honeysuckle flower, 15% of isatis root, 15% of hawthorn, 10% of eucommia leaf and and 10% of astragalus. Before the high temperature of the summer comes, the feed containing 2% of the compound Chinese herbal medicine water extraction solution is first fed to the tilapia for strengthening cultivation, the feed containing 1% of the compound Chinese herbal medicine water extraction solution is fed in high temperature season, the streptococcal disease infection resistant capability of the tilapia can be effectively improved, the survival rate after infection of pathogen can be increased. The Chinese herbal medicine materials in the feed are easy to obtain, are low in price, and are simple in production technology. The feed added with the compound Chinese herbal medicine has better palatability, the tilapia taking the feed may have less drug residue in the body, and the feed is in accord with requirements of green healthy aquatic products.
Owner:FRESHWATER FISHERIES RES CENT OF CHINESE ACAD OF FISHERY SCI

Polyvalent pneumococcal polysaccharide combination vaccine

The invention provides a coupling substance of pneumococcoal polysaccharide carrier protein, vaccines containing the coupling substance and process for preparation, wherein the coupling substance has the structural formula of Pr-L-Ps, wherein Pr is carrier protein, Ps is pneumococcoal polysaccharide, L is covalent bond or connection group, and the mass ratio of Ps:Pr=0.5-3.5:1. The coupling substance can form protection to the homogeneous pneumococcosis protomer which produces capsular polysaccharide compositions.
Owner:SHANGHAI JIANYI SCI & TECH DEV

Micro-organism preparation for preventing and curing streptococcicosis of Tilapia mossambica as well as preparation method and application thereof

The invention relates to a micro-organism preparation for preventing and curing streptococcicosis of Tilapia mossambica as well as a preparation method and an application thereof. The micro-organism preparation method for preventing and curing streptococcicosis of Tilapia mossambica comprises steps of compounding mixed vaccine with red Nocardia ATCC11653 and coral Nocardia ACCC40100, fermenting and cultivating the mixed vaccine with fermentation medium which is compounded of nitrogen source, carbon source and inorganic salt, and processing resultants into solid powder after the fermentation and cultivation. The micro-organism preparation for preventing and curing streptococcicosis of Tilapia mossambica, which provided by the invention, can reduce the content of ammonia nitrogen and nitrate nitrogen in the Tilapia mossambica breeding water body, antagonize the streptococcicosis of the Tilapia mossambica, reduce the accumulation of harmful substances of the middle and later breeding periods, enhance the immunity of the Tilapia mossambica,, achieve the aim of preventing and curing streptococcicosis of Tilapia mossambica, reduce the economic loss caused by diseases, and ensure the breeding output and quality of the Tilapia mossambica. The micro-organism preparation provided by the invention has advantages of convenience in use, small amount of usage and stable effect after use.
Owner:FRESHWATER FISHERIES RES CENT OF CHINESE ACAD OF FISHERY SCI

Tilapia mossambica source streptococcus agalactiae low virulent strain and application thereof

The invention relates to an aquaculture animal disease control technology and in particular relates to a tilapia mossambica source streptococcus agalactiae low virulent strain and application thereof. The tilapia mossambica source streptococcus agalactiae low virulent strain is YM001 and is preserved in CCTCC (China Center For Type Culture Collection) with the preservation number of CCTCCM2014045. The tilapia mossambica source streptococcus agalactiae low virulent strain is subjected to activation culture and fermentation culture, bacterial cells of a 106-109CFU / mL low virulent strain YM001 and a sterile phosphate buffered solution are mixed as a low virulent live vaccine used for preventing and controlling a tilapia mossambica streptococcus disease, the injection medication concentration for each tilapia mossambica is 105-108CFU, the oral medication concentration for each tilapia mossambica is 108-109CFU, and the soaking medication concentration is 107-108CFU / mL. The invention relates to strain identification, toxicity test, toxicity return safety and stability, immunogenicity and immune protection effect of a low virulent strain, and the tilapia mossambica streptococcus disease vaccine prepared by adopting the low virulent strain is good in immune protection effect and strong in safety and stability.
Owner:GUANGXI ACADEMY OF FISHERY SCI

Feed additive for improving liver function of tilapia and preventing streptococcicosis

The invention provides a feed additive for improving liver function of tilapia and preventing streptococcicosis. The feed additive is prepared from radix bupleuri, immature bitter orange, patrinia, salvia miltiorrhiza, rhizoma pinellinae praeparata, rhizoma alismatis, oriental wormwood, glossy privet fruit, liquorice, yeast cell wall extract, vitamin C, vitamin E, choline and pantothenic acid. The feed additive is added into the tilapia feed to remarkably improve the liver health condition of the tilapia, improvie the immunity and enhance the antistreptococcic ability, and besides, the antibiotics drugs are effectively reduced during feeding, and the side effect caused by the antibiotics is reduced.
Owner:广东海因特生物技术集团有限公司

Application of Chinese gall extract for controlling streptococcal disease in aquaculture animals

The invention discloses an application of a Chinese gall extract for controlling the streptococcal disease in aquaculture animals and in particular relates to an application of a Chinese gall extract for controlling the streptococcal disease in Tilapia fish. The invention also discloses a feed with the function of controlling the streptococcal disease in Tilapia fish, which contains the Chinese gall extract. Preferably, the content of the Chinese gall extract accounts for 1% to 10% of the total weight of the feed, more preferably 1% to 5%, and most preferably 1% to 2%. When the feed containing the Chinese gall extract is used for controlling the streptococcal disease, the Chinese gall extract is directly mixed in the common commercially-available feed before feeding, so as to overcome theproblem of needing to push aquaculture animals together before applying veterinary drugs in the soaking and oral intake mode, reduce the labor intensity of aquaculture farmers, reduce the man-made interference on aquaculture farmers (particularly Tilapia fish) and avoid the stress impact on Tilapia fish. Besides, the feed containing the Chinese gall extract has the advantages of less toxicity andmore safety.
Owner:GUANGXI INST OF BOTANY THE CHINESE ACAD OF SCI

Vaccine for edwardsiella disease and streptococcal disease in fish

Disclosed is a vaccine for edwardsiellosis and streptococcosis in a fish. Specifically, disclosed is a vaccine for edwardsiellosis in a fish, which comprises inactivated cells of (A) an Edwardsiella tarda strain derived from the target fish, and inactivated cells of (B) an Edwardsiella tarda strain derived from a fish other than the target fish, wherein, when the strain (A) is a typical Edwardsiella tarda strain, the strain (B) is an atypical Edwardsiella tarda strain, whereas when the strain (A) is an atypical Edwardsiella tarda strain, the strain (B) is a typical Edwardsiella tarda strain. Also specifically disclosed is a vaccine for edwardsiellosis and / or streptococcosis in a fish, which comprises the components mentioned above and inactivated cells of (C) Streptococcus iniae and / or Streptococcus parauberis.
Owner:KAWASAKIMITAKA +1

Recombinant lactococcus lactis and vaccine for Streptococcus agalactiae disease of Oreochromis sp.

The invention discloses recombinant lactococcus lactis based on the fbsA gene of Streptococcus agalactiae. The recombinant lactococcus lactis comprises the fbsA gene of Streptococcus agalactiae or segments of the fbsA gene, the fbsA gene or the segments of the fbsA gene preferably has (or have) a sequence shown in SEQ ID No. 1, the deposit number of the recombinant lactococcus lactis is CCTCC M 2020140, and expression of recombinant FbsA protein with a theoretical molecular weight of 34.6 kDa can be induced under the culture condition that niusin exists. The invention also provides a vaccine for the Streptococcus agalactiae disease of Oreochromis sp., and the vaccine is prepared from the recombinant lactococcus lactis, and is capable of producing protective antibodies in Oreochromis sp. after Oreochromis sp. is fed with the vaccine in an immune mode of oral gavage, so that Oreochromis sp. is assisted to resist infection of Streptococcus agalactiae effectively.
Owner:PEARL RIVER FISHERY RES INST CHINESE ACAD OF FISHERY SCI

Aquatic feed pre-digestion method and product and application thereof

The invention provides an aquatic feed pre-digestion method, and belongs to the technical field of feed processing. The pre-digestion method firstly mixes an aquatic feed, lactobacillus plantarum, bacillus cereus and molasses according to a mass ratio of 100:2-6:0.2-0.4:2-6,adjusts the water content of a mixture to 25-40% by adding water, and finally places a material to be fermented in a sealed package for fermenting for 18-36 hours to obtain a pre-digestion aquatic feed. The pre-digestion method can maximize the functions of detoxifying and antagonizing pathogenic bacteria of a functional microbial feed;the fermentation of the method is basically not limited by an environmental temperature, the equipment investment is small, the operation is simple, and the process is stable. The application of the methodto tilapia culture can effectively improve the growth performance of the tilapia and the ability to resist streptococcal infection, increase the survival rate after infection of thebacteria, and be a pre-digestion treatment technology for the aquatic feed before feeding which is worthy of popularization and application.
Owner:GUANGXI ACADEMY OF FISHERY SCI

Novel bacillus subtilis multi-valent vector-based vaccine and application thereof

The invention relates to a novel bacillus subtilis multi-valent vector-based vaccine and application thereof. The novel bacillus subtilis multi-valent vector-based vaccine comprises a bacillus subtilis recombination strain obtained by using a genetic engineering method, wherein the bacillus subtilis recombination strain is classified and named as bacillus subtilis HT5302 and is preserved in the China Center For Type Culture Collection (CCTCC) with a preservation number of CCTCC No:M2012380. The novel bacillus subtilis multi-valent vector-based vaccine is prepared by using the bacillus subtilis recombination strain as a core. A spore with a surface having no a streptococcus agalactiae 3-glyceraldehyde-phosphate dehydrogenase (GAPDH) protein can be generated through inducing the bacillus subtilis recombination strain, and secretes a fusion protein which formed by cell-penetrating peptide and vibrio anguillarum 3-GAPDH when germinating to form a nutrient cell. The novel bacillus subtilis multi-valent vector-based vaccine has a multi-valent protection function on bacterial diseases such as streptococcicosis, vibriosis, edwardsienosis and aeromonas hydrophila.
Owner:马悦 +1

Traditional Chinese medicine composition for treating streptococcicosis of tilapia mossambica

The invention relates to a traditional Chinese medicine composition for treating streptococcicosis of tilapia mossambica. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 10-15 parts of chinese barberry roots, 8-10 parts of asarum, 3-5 parts of negundo chastetree fruits, 3-4 parts of rhizoma alismatis, 1-2 parts of groundsel, 1-2 parts of salvia miltiorrhiza, 1-2 parts of platycladi seeds, 2-3 parts of bighead atractylodes rhizome and 3-5 parts of astragalus membranaceus. A preparation method comprises the following steps of: weighing the traditional Chinese medicine raw materials in parts by weight; mixing and crushing a mixture to be about 40-60 meshes; and then packaging to obtain the product. The traditional Chinese medicine composition disclosed by the invention can effectively prevent the streptococcicosis from breaking out in a cultivation process of the tilapia mossambica; the curing rate of cultivated fish schools with the disease is up to 50-70%, so that a passive situation that the tilapia mossambica of a whole pond die once the streptococcicosis breaks out is changed and the financial loss caused by the streptococcicosis of the tilapia mossambica is reduced; and therefore, the traditional Chinese medicine composition has the very important meaning to the development of the tilapia mossambica breeding industry.
Owner:北京康宝利华生物科技有限公司

Tilapia mossambica cultivation method

The invention provides a Tilapia mossambica cultivation method and belongs to the technical field aquaculture. The cultivation method includes: processing a cultivation pond, processing cultivation water, culturing algae and regulating water, putting Tilapia mossambica fry into the cultivation pond, feeding the Tilapia mossambica fry with preprocessed feed and the mixed powder of rhubarb, radix scutellariae and cortex phellodendri, regulating water in the early stage of cultivation, regulating water in the middle and late period of cultivation, and harvesting the Tilapia mossambica. The methodhas the advantages that the incidence rate of Tilapia mossambica streptococcicosis can be lowered effectively, the survival rate of the Tilapia mossambica can be increased, Tilapia mossambica growthcan be promoted, and Tilapia mossambica yield can be increased; the method does not antibiotics and is ecological and environmentally friendly; compared with the prior art, the method can lower the incidence rate of Tilapia mossambica streptococcicosis by more than 73.99%, increase the survival rate of the Tilapia mossambica by more than 31.22%, increase the average final weight of the Tilapia mossambica by more than 15.91% and increase the mu yield of the Tilapia mossambica by more than 52.23%.
Owner:GUANGXI ACADEMY OF FISHERY SCI

Antibacterial Chinese herbal medicine compound for fishes as well as preparation method and application of antibacterial Chinese herbal medicine compound

The invention discloses an antibacterial Chinese herbal medicine compound for fishes as well as a preparation method and application of the antibacterial Chinese herbal medicine compound. The Chinese herbal medicine compound is prepared from the following crude drugs in percentage by weight: 10-20% of Chinese galls, 20-40% of immature fruits of trminalia chebula, 10-30% of pomegranate barks, 8-20% of suberect spatholobus stems and 6-20% of water banyan flowers. The crude drugs are compact in combination, the production method is simple and convenient, and the medication cost is not high. The antibacterial Chinese herbal medicine compound disclosed by the invention is capable of effectively inhibiting and killing various aquatic pathogenic bacteria, has a particularly good streptococcus-resistant effect and is an ideal safe and green oral administration product for preventing and treating bacterial diseases of fishes and particularly streptococcal diseases of tilapia mossambica; and the product is degradable and residue-free in environments and fish bodies, so that the quality safety of water environments and aquatic products can be ensured, and meanwhile, the condition that pathogenic bacteria are induced to generate drug-resistant strains is avoided.
Owner:JINAN UNIVERSITY

Streptococcus agalactiae BibA recombinant protein, as well as coding gene preparation method and application thereof

The invention discloses streptococcus agalactiae BibA recombinant protein, as well as a coding gene, a preparation method and an application thereof. The streptococcus agalactiae BibA recombinant protein provided by the invention is a protein sequence as shown in sequence No. 2. The invention also provides the coding gene, the preparation method and application of the protein. The streptococcus agalactiae BibA recombinant protein has the beneficial effects that streptococcus agalactiae is used as a research object, streptococcus agalactiae DNA is cloned to obtain a BibA gene, the cloning and sequencing of the gene sequence are completed, the prokaryotic expression and immunizing protection of the streptococcus agalactiae are researched, a vaccine development candidate antigen with high specificity and immune protection force is obtained, and the foundation is laid for prevention of streptococcus agalactiae diseases. The streptococcus agalactiae BibA recombinant protein has the advantages that the streptococcus agalactiae BibA gene is obtained by cloning, BibA recombinant expression plasmids are constructed, the BibA recombinant protein is obtained, westernblot detection results show that the BibA recombinant protein has relatively good reactogenicity, and animal (rat) experiments prove that the recombinant protein has certain protectiveness.
Owner:LANZHOU INST OF ANIMAL SCI & VETERINARY PHARMA OF CAAS

Traditional Chinese veterinary medicine compound preparation Shuanghuanglian for injection as well as preparation technology and application thereof

The invention relates to a traditional Chinese veterinary medicine compound preparation Shuanghuanglian for injection as well as a preparation technology and an application thereof. The compound preparation comprises the components in parts by weight as follows: 1300-1700 parts of honeysuckle, 1300-3700 parts of radix scutellariae and 2500-7500 parts of fructus forsythiae. Slow-release accessories comprise 150 parts of hydroxymethyl propyl cellulose and 100 parts of sodium carboxymethyl cellulose. The compound preparation contains the slow-release accessories, so that the injection time of large animals can be reduced, and the stress response of the large animals can be reduced. The traditional Chinese veterinary medicine compound preparation for injection has antiviral, antibacterial, anti-inflammatory, antipyretic, analgesic, immunity-improving effects and the like. Veterinarian clinic proves that the compound preparation can be used for treating epidemic diarrhea; transmissible gastroenteritis; necrotic enteritis; septicemia caused by various epidemic diseases; cough, dyspnea, skin cyanosis, arthrocele which are caused by chromic respiratory diseases such as streptococcosis, haemophflussuis, contagious porcine pleuropneumonia, swine plague and the like; and porcine reproductive and respiratory syndrome and cow mastitis.
Owner:QINGDAO AGRI UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products